J
Joshua D. Dowell
Researcher at The Ohio State University Wexner Medical Center
Publications - 64
Citations - 3434
Joshua D. Dowell is an academic researcher from The Ohio State University Wexner Medical Center. The author has contributed to research in topics: Inferior vena cava & Inferior vena cava filter. The author has an hindex of 17, co-authored 64 publications receiving 3212 citations. Previous affiliations of Joshua D. Dowell include University of Virginia & Indiana University – Purdue University Indianapolis.
Papers
More filters
Journal ArticleDOI
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts
Charles E. Murry,Mark H. Soonpaa,Hans Reinecke,Hidehiro Nakajima,Hisako O. Nakajima,Michael Rubart,Kishore B.S. Pasumarthi,Kishore B.S. Pasumarthi,Jitka A. I. Virag,Stephen H. Bartelmez,Veronica Poppa,Gillian Bradford,Joshua D. Dowell,David A. Williams,David A. Williams,Loren J. Field +15 more
TL;DR: Results indicate that haematopoietic stem cells do not readily acquire a cardiac phenotype, and raise a cautionary note for clinical studies of infarct repair.
Journal ArticleDOI
Myocyte and myogenic stem cell transplantation in the heart.
TL;DR: A review of studies wherein myocytes or stem cells with myogenic potential have been transplanted into the heart and issues pertaining to the tracking and functional consequences of cell transplantation are discussed.
Journal ArticleDOI
Stem cell therapy for ischemic heart disease.
Rutger J. Hassink,Joshua D. Dowell,Aart Brutel de la Rivière,Pieter A. Doevendans,Loren J. Field +4 more
TL;DR: Surprisingly, the observation that non-cardiomyogenic cells could also improve cardiac function indicates that functional integration of donor cells might not be required to achieve a beneficial effect.
Journal ArticleDOI
A Systematic Review of Acquired Uterine Arteriovenous Malformations: Pathophysiology, Diagnosis, and Transcatheter Treatment
TL;DR: Low-level evidence supports the role of TCE, including in the event of persistent bleeding following initial embolization, for the treatment of acquired uterine AVMs, and the variety of embolic agents and laterality of approach delineate the importance of refining procedural protocols.
Journal ArticleDOI
Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies.
TL;DR: This review explores recent advances in liver-directed techniques for HCC including bland transarterial embolization, chemoembolized, radioembolizations, and ablative therapies, with a focus on patient selection, procedural technique, periprocedural management, and outcomes.